A practical reference on secretagogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-19. Anything still debated is marked as such rather than presented as settled.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
Published animal and early human work describes growth hormone release that is separated from comparable rises in adrenocorticotropic hormone and cortisol. Prolactin changes are reported as small in the same studies. Selectivity is attributed to binding at the ghrelin receptor and to the downstream signaling that follows, rather than to differences in how quickly the peptide is cleared. Authors commonly label the compound selective rather than potent, because the same mass produces a smaller growth hormone response than some older secretagogues tested in parallel. Whether that profile holds across species and routes of administration remains an open question.
Human data remain limited and come mainly from small, short-term studies conducted decades ago. The peptide has not received approval as a medicine from major regulators, so current availability is largely as a research chemical. Reported effects on growth hormone pulsatility, appetite, and body composition should be read as preliminary, since few independent groups have replicated the original findings. Analytical characterization of research-grade material varies between suppliers, which complicates comparison across studies. Regulatory status also differs by country, and some jurisdictions classify it as a prescription-only or otherwise restricted item.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentapeptide | Growth hormone secretagogue family |
| Molecular mass | Approximately 711.9 Da | Free base, calculated value |
| Receptor target | GHS-R1a, the ghrelin receptor | Agonist activity reported |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | C-terminal amide |
| Reported selectivity | Little change in ACTH, cortisol, prolactin | Based mainly on animal data |
Signal transduction begins when the peptide binds GHSR-1a on pituitary somatotrophs. The receptor couples to Gq/11 proteins, activating phospholipase C, which cleaves phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol. Inositol trisphosphate releases calcium from intracellular stores, and the resulting rise in cytosolic calcium drives growth hormone vesicle fusion. Concurrent Gs coupling and cyclic AMP elevation have also been reported, and the relative contribution of each arm to the overall secretory response is not fully settled.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
对 ipamorelin 的常规表征以反相高效液相色谱测定纯度，检测波长多设为 214 nm，因为肽键在该波长有较强吸收。身份确认通常借助电喷雾电离质谱或串联质谱，将实测分子量与理论值逐项比对。序列层面可用肽图分析或氨基酸分析进一步验证。这些手段组合起来，可以分别覆盖纯度、身份与序列三个不同层次的信息。
杂质谱一般包含缺失序列片段、差向异构体、氧化产物以及残留溶剂或反离子，其中组氨酸与芳香残基的氧化常被重点关注。反相色谱中这类杂质往往紧邻主峰洗脱，因此方法需要足够的分离度并经过系统适用性验证。纯度百分比的解读依赖于检测波长与梯度条件，不同实验室公布的数字不宜直接横向比较。参考标准品有助于跨批次对照，但其自身赋值同样需要可追溯来源。
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, a structure that differs from natural ghrelin in length and in the presence of non-natural amino acid residues. Early laboratory work described it as a comparatively selective agent that stimulates growth hormone release with limited effect on other pituitary hormones. The compound is supplied as a lyophilized solid for research use and has no identified natural source in the body.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
state of matter The condition of matter existing in a distinct, homogeneous, macroscopic form. Solid, liquid, gas, and plasma are the four traditional states of matter and the most well-known. See also phase.
can be quite complex, there is typically one rate-determining enzymatic step that allows this reaction to be modelled as a single catalytic step with an apparent unimolecular rate constant kcat. If the reaction path proceeds over one or several intermediates, kcat will be a function of several elementary rate constants, whereas in the simplest case of a single elementary reaction (e.g. no intermediates) it will be identical to the elementary unimolecular rate constant k2. The apparent unimolecular rate constant kcat is also called turnover number, and denotes the maximum number of enzymatic reactions catalysed per second. The Michaelis–Menten equation describes how the (initial) reaction rate v0 depends on the position of the substrate-binding equilibrium and the rate constant k2.
Hydrogen thus forms a covalent H2 molecule, and boron forms a giant covalent structure based on icosahedral B12 clusters. In a metal, the bonding and antibonding orbitals have overlapping energies, creating a single band that electrons can freely flow through, allowing for electrical conduction.
A mummy is a dead human or an animal whose soft tissues and organs have been preserved by either intentional or accidental exposure to chemicals, extreme cold, very low humidity, or lack of air, so that the recovered body does not decay further if kept in cool and dry conditions. Some authorities restrict the use of the term to bodies deliberately embalmed with chemicals, but the use of the word to cover accidentally desiccated bodies goes back to at least the early 17th century. Mummies of humans and animals have been found on every continent, both as a result of natural preservation through unusual conditions, and as cultural artifacts. Over one million animal mummies have been found in Egypt, many of which are cats. Many of the Egyptian animal mummies are sacred ibis, and radiocarbon dating suggests the Egyptian ibis mummies that have been analyzed were from a time frame that falls between approximately 450 and 250 BC. The earliest discovered evidence of deliberate mummification in human cultures now extends to approximately 10,000 BC and is documented to have existed across Southeast Asia, China, New Guinea, and Australia in burials discovered there, and is prompting research to cultures documented to 20,000 years ago for evidence of use of the same mummification methods. In addition to the mummies of ancient Egypt, deliberate mummification was a feature of several ancient cultures in areas of America and Asia with very dry climates. The Spirit Cave mummies of Fallon, Nevada, in North America were accurately dated at more than 9,400 years old.
As governor, Newsom has focused on infrastructure, housing, climate, gun control and LGBTQ rights. In 2025, he began hosting the podcast This Is Gavin Newsom, which has featured guests from across the political spectrum. He oversaw the passage of California Proposition 50, a gerrymandering proposal developed in response to 2025 Texas redistricting. Newsom is a potential 2028 presidential candidate.
Sources: en.wikipedia.org
== Description == It produces a "global snapshot" of all the ribosomes actively translating in a cell at a particular moment, known as a translatome. Consequently, this enables researchers to identify the location of translation start sites, the complement of translated ORFs in a cell or tissue, the distribution of ribosomes on a messenger RNA, and the speed of translating ribosomes. Ribosome profiling targets only mRNA sequences protected by the ribosome during the process of decoding by translation unlike RNA-Seq, which sequences all of the mRNA of a given sequence present in a sample. This technique is also different from polysome profiling.
Seaborg was notified and the team left to sleep. Additional analysis and further experimentation showed the produced mendelevium isotope to have the expected mass of 256 and decay by electron capture to fermium-256 (half-life 157.6 minutes), the source of the observed fission.
Consultant Urologist, South Tyneside and Sunderland NHS Foundation Trust. For services to the NHS. Dr. Benjamin Marc Ellis. For services to Healthcare, to Equality and to the Jewish Community. Audley Horace English. Co-Founder, Society of Black Architects. For services to Architecture and Sustainability. Professor Stephen James Weston Evans. Emeritus Professor of Pharmacoepidemiology, London School of Hygiene and Tropical Medicine. For services to the Safety of Medicines. Stephen Wynne Evans. Founder, Belief. For voluntary and charitable services in North Wales. Helen Adesuwa Imatitkua Fadipe. Founder and Chair, BAME Planners Network. For services to Town Planning. Paul Fairweather. Trustee, Breakthrough Ltd. For services to Disabled People and to the LGBT Community in the North West. Catherine Susan, Baroness Fall. Lately Non Executive Director, Cultural Recovery Board. For services to Culture. Rhiane Estelle Fatinikun. Founder, Black Girls Hike. For services to Nature and to Diversity. Julie Patricia Felix. For services to Dance Education. James St John Fenny. Head of Office, Public Defender Service and Transplant Surgery Ambassador. For services to Criminal Justice and to Organ Donor Awareness. Dr. Julia Helen Fentem. Executive Vice President, Safety, Environmental and Regulatory Science, Unilever. For services to Human Health and Animal Welfare. Jacqueline Ferguson. President, London College of Dance Network and Volunteer, Healthwatch (Kensington and Chelsea). For services to the community in London. Lucy Catherine Ferguson. Founder and Director, Mediorite.
=== By U-Pb age discordance === Before applying detrital zircon ages, they should be evaluated and screened accordingly. In most cases, data are compared with U-Pb Concordia graphically. For a large dataset, however, data with high U-Pb age discordance (>10 – 30%) are filtered out numerically. The acceptable discordance level is often adjusted with the age of the detrital zircon since older population should experience higher chances of alteration and project higher discordance. (See Uranium–lead dating)
Sources: en.wikipedia.org
In the United States, dog foods labelled as "complete and balanced" must meet standards established by the Association of American Feed Control Officials (AAFCO), either by meeting a nutrient profile or by passing a feeding trial. The Dog Food Nutrient Profiles were last updated in 2016 by the AAFCO's Canine Nutrition Expert Subcommittee. Critics argue that due to the limitations of the trial and the gaps in knowledge within animal nutrition science, the term "complete and balanced" is inaccurate and even deceptive. An AAFCO panel expert has stated that "although the AAFCO profiles are better than nothing, they provide false securities." Certain manufacturers label their products with terms such as "premium", "ultra premium", "natural", and "holistic". Such terms currently have no legal definitions and are not regulated. There are also varieties of dog food labeled as "human-grade food." Although no official definition of this term exists, the assumption is that other brands use foods that would not pass US Food and Drug Administration inspection according to the Pure Food and Drug Act or the Meat Inspection Act. The ingredients on the label must be listed in descending order by weight before cooking. This means before all of the moisture is removed from the meat, fruits, vegetables and other ingredients used.
Lewandowski that he ought to realise that his position here was a delicate one... and I added it was highly desirable that his office should not be situated in a building with the Bureau of Polish propaganda". Undercover and illicit activities also started as early as 11 March 1920, when the Earl of Derby reported a decision of the Allied Council of Ambassadors in Paris to make representations to the Polish government regarding the violations of the frontiers of the Marienwerder Plebiscite Area towards Germans by Polish soldiers. Beaumont reported from Marienwerder at the end of March that "no change has been made in the methods of Polish propaganda. Occasional meetings are held, but they are attended only by Poles in small numbers". He continued to note that "acts and articles violently abusive of everything German in the newly founded Polish newspaper appear to be the only (peaceful) methods adopted to persuade the inhabitants of the Plebiscite areas to vote for Poland".
rough endoplasmic reticulum (RER) A type of membrane in the endoplasmic reticulum with numerous ribosomes conspicuously attached to its surface, in contrast to the "smooth" endoplasmic reticulum which lacks ribosomes. The rough ER serves as the site of protein synthesis for the majority of the cell's secreted and transmembrane proteins, as well as the site of synthesis of membrane lipids. It may be continuous with the smooth ER or exist separately.
Sources: en.wikipedia.org
Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release by activating the ghrelin receptor. It is handled as a research tool rather than as a licensed therapeutic product. Its short chain length makes it comparatively simple to synthesize and analyze.
Both bind the same receptor, but ghrelin is a 28-amino-acid hormone with roles in appetite and energy balance. Ipamorelin is a much smaller synthetic peptide selected for growth hormone release with limited effect on appetite signaling in animal models. The full overlap between their effects is not completely mapped.
Most published data come from animal studies and a small number of human trials. Findings on growth hormone release are reasonably consistent, while long-term effects and direct comparisons with other secretagogues remain incompletely studied. Open questions include duration of action across different populations.
It has not been approved as a therapeutic by major regulators, and the human trial record is small and dated. Material available today is mostly sold as a research chemical for laboratory use. Approval and restriction status varies by country.